Jun 7 |
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
|
Jun 7 |
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
|
Jun 7 |
FDA places full clinical hold on Biomea Fusion’s diabetes trials of BMF-219
|
Jun 6 |
Biomea stock plunges 62% after hours on FDA clinical hold
|
Jun 6 |
Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
|
Jun 6 |
Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations
|
Jun 3 |
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
|
May 30 |
Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes
|
May 28 |
Is Biomea Fusion (NASDAQ:BMEA) In A Good Position To Invest In Growth?
|
May 3 |
Biomea Fusion GAAP EPS of -$1.09 misses by $0.02
|